Press "Enter" to skip to content

Risk of Guillain-Barre syndrome 6 times higher after COVID infection, study suggests

A new study from Israel ties COVID-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a decreased risk of the rare but serious autoimmune disease.